Label: ZINC THERAPY- pyrithione zinc soap
- NDC Code(s): 71819-001-01, 71819-001-04, 71819-001-44
- Packager: D3 Development, Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated March 24, 2020
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- ACTIVE INGREDIENT
- PURPOSE
- INDICATIONS & USAGE
- WARNINGS
- ASK DOCTOR
- WHEN USING
- STOP USE
- KEEP OUT OF REACH OF CHILDREN
- DOSAGE & ADMINISTRATION
- STORAGE AND HANDLING
- INACTIVE INGREDIENT
- QUESTIONS
- SPL UNCLASSIFIED SECTION
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
ZINC THERAPY
pyrithione zinc soapProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:71819-001 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PYRITHIONE ZINC (UNII: R953O2RHZ5) (PYRITHIONE ZINC - UNII:R953O2RHZ5) PYRITHIONE ZINC 2 g in 100 g Inactive Ingredients Ingredient Name Strength SODIUM CHLORIDE (UNII: 451W47IQ8X) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) WATER (UNII: 059QF0KO0R) SODIUM COCOATE (UNII: R1TQH25F4I) GLYCERIN (UNII: PDC6A3C0OX) OATMEAL (UNII: 8PI54V663Y) SODIUM PALM KERNELATE (UNII: 6H91L1NXTW) OLIVE OIL (UNII: 6UYK2W1W1E) SODIUM PALMATE (UNII: S0A6004K3Z) .ALPHA.-TOCOPHEROL ACETATE, D- (UNII: A7E6112E4N) PENTASODIUM PENTETATE (UNII: 961TOZ5L7T) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:71819-001-01 28 g in 1 CELLO PACK; Type 0: Not a Combination Product 05/01/2018 2 NDC:71819-001-04 113 g in 1 CELLO PACK; Type 0: Not a Combination Product 05/01/2018 3 NDC:71819-001-44 226 g in 1 CELLO PACK; Type 0: Not a Combination Product 03/24/2020 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part358H 05/01/2018 Labeler - D3 Development, Inc. (043195877)